HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Margareta Nordlander Selected Research

BIIE 0246

9/2006Ventricular fibrillation induced by ischemia-reperfusion is not prevented by the NPY Y2 receptor antagonist BIIE0246.
10/2005Influence of endogenous neuropeptide Y (NPY) on the sympathetic-parasympathetic interaction in the canine heart.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Margareta Nordlander Research Topics

Disease

2Myocardial Ischemia (Ischemic Heart Diseases)
09/2006 - 01/2004
1Cardiac Arrhythmias (Arrythmia)
06/2007
1Heart Failure
06/2007
1Myocardial Infarction
06/2007
1Sudden Death
06/2007
1Ischemia
09/2006
1Ventricular Fibrillation
09/2006
1Ventricular Tachycardia
09/2006
1Tachycardia (Tachyarrhythmias)
10/2005
1Bradycardia
10/2005
1Reperfusion Injury
01/2004
1Infarction (Infarctions)
01/2004
1Hypertension (High Blood Pressure)
05/2002

Drug/Important Bio-Agent (IBA)

3neuropeptide Y2 receptorIBA
06/2007 - 10/2005
2NeuropeptidesIBA
06/2007 - 09/2006
2BIIE 0246IBA
09/2006 - 10/2005
2clevidipineFDA Link
01/2004 - 05/2002
1Anti-Arrhythmia AgentsIBA
06/2007
1Neuropeptide YIBA
09/2006
1Calcium Channel Blockers (Blockers, Calcium Channel)IBA
05/2002

Therapy/Procedure

1Ligation
06/2007
1Vagus Nerve Stimulation
10/2005